A pilot study of the effect of transcranial magnetic stimulation treatment on cognitive dysfunction associated with post COVID‐19 condition
暂无分享,去创建一个
Y. Noda | K. Hirahata | R. Kitahata | Ryota Osawa | Akiko Sato | Kyoshiro Fujii | Mio Iwasa | Y. Nagano
[1] P. Wilmes,et al. Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity , 2022, Open forum infectious diseases.
[2] Masaru Mimura,et al. TMS Database Registry Consortium Research Project in Japan (TReC-J) for Future Personalized Psychiatry , 2022, Journal of personalized medicine.
[3] J. Rungby,et al. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables , 2021, European Neuropsychopharmacology.
[4] Paul J. Harrison,et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA , 2020, The Lancet Psychiatry.
[5] D. Chan,et al. The cognitive consequences of the COVID-19 epidemic: collateral damage? , 2020, Brain communications.
[6] Cheng-Ta Li,et al. Antidepressant Efficacy of Prolonged Intermittent Theta Burst Stimulation Monotherapy for Recurrent Depression and Comparison of Methods for Coil Positioning: A Randomized, Double-Blind, Sham-Controlled Study , 2020, Biological Psychiatry.
[7] Jonathan Downar,et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial , 2018, The Lancet.
[8] Bruce Luber,et al. Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS) , 2014, NeuroImage.
[9] Mark S. George,et al. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications , 2009, Brain Stimulation.